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Microtubules reorganized
Microtubule reorganization during differentiation is not well 
understood. Transgenic mice that express fluorescently labeled 
microtubules in the epidermis confirmed a dynamic differen-
tiation-specific rearrangement of microtubules. Disruption of 
desmoplakin (DP), a protein that connects desmosomal cad-
herin to the intermediate filament cytoskele ton and is essential 
for desmosome formation, resulted in a loss of the microtubule-
organizing center and accumulation of cortical microtubules. 
The centrosomes, which remained intact, no longer anchored 
the microtubules during differentiation but were not responsible 
for the microtubule reorganization. Ninein, a marker of micro-
tubule anchoring, was depleted at the centrioles and relocalized 
to cell–cell junctions upon induction of terminal differentiation 
in epidermal cultures. Thus, Lechler and Fuchs probed a com-
plicated developmental process and implicated DP as an essen-
tial player in microtubule reorganization during differentiation. 
(J Cell Biol 176:147–54, 2007)
Ceramide inhibits myogenesis
The involvement of ceramide, a central molecule in the sphin-
golipid pathway, in differentiation is an area of great interest. 
Using a model of in vitro myogenesis, Mebarek and colleagues 
discovered that ceramide plays an integral regulatory role in the 
myogenic process. These researchers used ceramide de novo 
synthesis inhibitors to show that decreasing ceramide levels 
promoted differentiation in these myogenic cells via enhanced 
expression of muscle-specific proteins and accelerated myo-
blast fusion. In addition, ceramide accumulation decreased the 
expression of phospholipase D1, an enzyme that is involved in 
actin cytoskeleton rearrangements in myogenic differentiation. 
These results are intriguing, as ceramide generation has gener-
ally been linked to cell-cycle arrest, apoptosis, and differentia-
tion; however, these data identify a negative role for ceramide 
in myogenic differentiation. These data suggest that future thera-
pies aimed at increasing muscle mass by enhancing progenitor 
commitment may focus on blockage of the ceramide signaling 
pathway. (J Cell Sci 120:407–16, 2007)
Tumor invasion by number
While tumors are believed to evolve by clonal selection of pro-
liferating cell populations that accumulate mutations and com-
pete for nutrients and space, the mechanism for selection for 
invasive cancer cells is still a mystery. Anderson and colleagues 
used a multiscale mathematical model of cancer invasion based 
on both the behavior of individual cells (growth, division, move-
ment, and interaction) and the microenvironment (use of nutri-
ents and production of enzymes). This hybrid model combined 
both discrete stochastic and continuum deterministic variables. 
According to these simulations, harsh conditions, includ-
ing bumpy or grainy extracellular matrices and low oxygen, 
favored the emergence of morphologically invasive tumors with 
fingering margins and dominance by one or a few aggressive 
phenotypes. Mild conditions led to the coexistence of aggres-
sive and less aggressive phenotypes, a lack of clonal domi-
nance, and noninvasive tumors with smooth edges. Moreover, 
this model predicts that invasive tumor properties are reversible 
under favorable microenvironmental conditions. Thus, thera-
pies aimed at cancer–microenvironment interactions may serve 
patients better than damaging treatments such as chemotherapy 
or antiangiogenic therapy. (Cell 127:905–15, 2006)
GATA-1 mutation in porphyria
Congenital erythropoietic porphyria (CEP) is an autosomal 
recessive trait typically caused by mutations in the gene that 
encodes uroporphyrinogen III synthase (UROS). A 3-year-old 
boy presented with photosensitiviy, fluorescent urine, hirsutism, 
splenomegaly, fluorescing erythrocytes, and decreased UROS 
activity. These characteristics confirmed CEP diagnosis; howev-
er, other findings, including thalassemia-like anemia, increased 
fetal hemoglobin, and thrombocytopenia, confounded the 
clinical diagnosis. Lacking identifiable debilitating mutations in 
genes encoding UROS or globins, Phillips and colleagues dis-
covered an X-linked trans-acting mutation in the GATA-binding 
factor 1 (GATA-1) gene. This transcription factor is critical for 
normal erythropoiesis, globin gene expression, and megakaryo-
cyte development and, in addition, regulates UROS expression 
in developing erythrocytes. This report is the first to describe 
a trans-acting mutation affecting CEP. The authors speculated 
that the mutation in GATA1 dramatically alters binding to pal-
indromic GATA sites, which are employed in the regulation of 
UROS expression. (Blood 109:2618–21, 2007)
Claudin regulates cell adhesion
The barrier function of epithelial cells stems from the tight seal 
between adjacent cells and impedes the flow of ions, nutrients, 
and pathogens. Little is known about tight junction proteins 
in human esophagus and their role in malignancy. Thus, Lioni 
and colleagues recently demonstrated that claudin-7, as well as 
claudin-1 and claudin-4, is expressed at the membrane of kera-
tinocytes, but expression becomes deregulated as the keratino-
cytes progress to squamous-cell carcinoma (SCC). Knockdown 
of claudin-7 expression using small interfering RNA decreased 
E-cadherin expression and resulted in poor cell–cell adhesion 
in SCC cell lines. Lentiviral expression of claudin-7 restored 
these phenotypes in these cells, implicating claudin-7 in 
E-cadherin regulation and maintenance of cell–cell adhesion. 
These findings suggest that loss of claudin-7 expression may be 
an early event in tumorigenesis, as, during oncogenic transfor-
mation, tumor cells lose tight junction function. This abnormal 
function results in altered tissue architecture and paves the way 
for tumor invasion. (Am J Pathol 170:709–21, 2007)
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